Lymphoid enhancer factor-1 and β-catenin inhibit Runx2-dependent transcriptional activation of the osteocalcin promoter

Medicine & Life Sciences

• Lymphoid Enhancer-Binding Factor 1 100%
• TCF Transcription Factors 78%
• Catenins 72%
• Osteocalcin 62%
• Transcriptional Activation 52%
• Osteoblasts 24%
• Binding Sites 14%
• High Mobility Group Proteins 9%
• Osteogenesis 5%
• Transcription Factors 4%
• Bone and Bones 3%
• Cell Line 3%
• Mutation 3%
• DNA 3%
• Genes 2%

Chemical Compounds

• Enhancer 68%
• Effector 62%
• Mutation 48%
• Compound Mobility 43%
• Protein 23%